Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2026–2029 · award
Targeting lysosomal lipid acquisition to suppress cancer progression
Lingjie Sang · The University Of Texas Southwestern Medical Center (ut Southwestern)
2026–2030 · award
Targeting a post-transcriptional regulatory node in myeloid leukemia
Bruno Di Stefano · Baylor College of Medicine
2026–2028 · award
Tipping point at the onset of malignant glioma
Hui Zong · University of Virginia
2026–2028 · award
Paralyzing plasticity: Developing a SOX9 inhibitor for colorectal cancer treatment
Nilay Sethi · Dana-Farber Cancer Institute
2026–2028 · award
Understanding Tissue Specificity of Metabolic Mutations in Cancer
Lucas Sullivan · Fred Hutch Cancer Center
2026–2030 · award
LSD1 inhibition for the prevention and treatment of skin cancer
Brian Capell · The Trustees Of The University Of Pennsylvania
2026–2030 · award
Developing a Targeted Community-Based Precision PSA Screening and Cohort Registry to Address Prostate Cancer Disparities
Brandon Mahal · University of Miami
2026–2027 · award
Role of myeloid cells in regulating epithelial cell antigen presentation in oral cancer progression
Christian Young · University Of Colorado Denver, Amc And Dc
2026–2028 · award
Galvanizing exocytosis for improved cancer immunotherapy
Jose Rizo-Rey · The University Of Texas Southwestern Medical Center (ut Southwestern)
2026–2029 · award
Does a multicomponent exercise program affect balance among endometrial and ovarian cancer patients undergoing adjuvant chemotherapy?
Salvatore Ficarra · Dana-Farber Cancer Institute
2026–2028 · award
Iowa Cancer Research Experience (ICARE)
Jon Houtman · University of Iowa
2026–2031 · award
Implementation of a communication and linkage intervention to improve the breast cancer screening cascade among women with serious mental illness
Karly Murphy · Regent University
2026–2030 · award
The impact of aging on bladder cancer
Peter Mullen · University of Southern California
2026–2030 · award
Understanding the impact of new-generation incretin-mimetic weight loss agents in breast cancer
Erin Giles · Regent University
2026–2029 · award
Role of SPP1 positive macrophages in the tumor immune microenvironment of pancreatic cancer
Yasuhiro Kikuchi · Johns Hopkins University
2026–2028 · award
Targeting Platelets to Enhance Immune Checkpoint Inhibitor Responses in Breast Cancer
Elisabeth Battinelli · Brigham and Women's Hospital
2026–2028 · award
Validation of non-canonical tumor antigens as natural targets of intra-tumoral immunity
Mark Lee · Yale University
2026–2028 · award
Investigating the drivers of intra-tumoral heterogeneity in small cell lung cancer
Debadrita Bhattacharya · The Board Of Trustees Of The Leland Stanford Junior University
2026–2028 · award
Surfaceome Target Discovery for Next-Generation Therapies in Biliary Tract Cancers
William Sellers · Broad Institute
2026–2030 · award
The role of adipocyte-secreted paracrine factors in obesity-accelerated breast cancer.
Keren Hilgendorf · University of Utah
2026–2030 · award
Discovery of TRPM8 Antagonists for chemotherapy-induced peripheral neuropathy
Velvet Journigan · University of Pittsburgh
2026–2030 · award
Institutional Research Grant
Irina Stepanov · Twin Cities Orthopedics
2026–2030 · award
Institutional Research Grant
Leonidas Platanias · Northwestern University
2026–2028 · award
Defining the Mechanisms of Resistance to Mutant-selective KRAS Inhibitors in KRAS-mutant Pancreatic Cancer
Qingxiang Lin · Massachusetts General Hospital
2026–2029 · award
Identifying neurofunctional signatures of radiotherapy induced cognitive decline in glioma
Jiwandeep Kohli · Regent University
2026–2028 · award
IUSCCC Cancer Research Post-Baccalaureate Fellows Program
Dr. Ann C. Kimble-Hill · Indiana University
2026–2029 · award
Therapeutic resistance to multi-RAS inhibitors in KRAS-mutant lung cancer
Suyeon Kim · Columbia University Irving Medical Center
2026–2030 · award
ACS Institutional Research Grant
Alan Pollack · Sylvester Comprehensive Cancer Center
2026–2029 · award
LARP1 as a critical node for integrative signaling in cancer
Sathyen Prabhu · University of Pittsburgh
2026–2030 · award
Access EquiTy and Causal EffecTs of GluCagon LiKe Peptide 1 Agonist on HepatoCellular Carcinoma PreveNtion and SurvivOrship in Patients With Cirrhosis
Mohamed Elsaid · The Ohio State University
2026–2028 · award
Regulation of the NLRP3-inflammasome through the aryl hydrocarbon receptor (AHR) influences hematopoietic stem cell development
Morgan Walcheck · Boston Children's Hospital
2026–2027 · award
Regulation of KRAS expression in PDAC via promoter DNA structural dynamics
Amy Whitaker · Fox Chase Cancer Center
2026–2030 · award
p38d in tumor-associated “emergency” granulopoiesis and immunosuppression
Xia Liu · University Of Kentucky Research Foundation
2026–2028 · award
Aurora A-Mediated Stabilization of c-MYC: Structural and Allosteric Mechanisms Regulating Ubiquitination
Jason Jones · Twin Cities Orthopedics
2026–2027 · award
Genetic Epidemiology of Lymphoma: Risk and Heterogeneity
Nicholas Boddicker · Mayo Clinic
2026–2029 · award
Mitochondrial Dysfunction-Induced PKA Signaling in Hepatocellular Carcinoma
Su Hyun Kim · Regent University
2026–2030 · award
Germline-somatic interactions as drivers and therapeutic targets in bladder cancer
Bishoy Faltas · Weill Cornell Medicine
2026–2029 · award
Osteopontin promotes epithelial plasticity in pancreatic tumorigenesis
Katherine Ankenbauer · Vanderbilt University
2026–2029 · award
Defining the molecular mechanisms of cereblon-mediated protein degradation
Zeba Rizvi · Scripps Research Institute
2026–2028 · award
Direct identification and prioritization of shared noncanonical tumor-specific antigens to generate effective off-the-shelf cancer vaccines
Catherine Wu · Dana-Farber Cancer Institute